LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranoviaâ„¢.
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product ...
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product ...
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound ... that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives to be ...
American pharmaceutical company Eli Lilly has started selling higher doses of its popular weight-loss drug Zepbound in ... prescriptions of the two higher dose vials within 45 days of their ...